Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

scientific article

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/J.GASTRO.2008.03.023
P3181OpenCitations bibliographic resource ID1530069
P932PMC publication ID2653457
P698PubMed publication ID18485912
P5875ResearchGate publication ID5364459

P50authorAlessio FasanoQ18686101
Terez Shea-DonohueQ37067154
Stefanie N. VogelQ92126561
P2093author name stringPrasad Rallabhandi
Bao Lu
Craig Gerard
Sarah Netzel-Arnett
Karen Thomas
Karen M Lammers
Ruliang Lu
Sefik Alkan
Julie Brownley
Toni Antalis
Amir Tamiz
P2860cites workCXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gammaQ22254641
Toll-like receptor signallingQ24570126
Requirement of the chemokine receptor CXCR3 for acute allograft rejectionQ24676298
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitisQ28213277
Identification of tissue transglutaminase as the autoantigen of celiac diseaseQ28243044
Chemokines--chemotactic cytokines that mediate inflammationQ29616433
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone ratsQ33864397
Danger signals: SOS to the immune systemQ33931055
Current concepts of celiac disease pathogenesisQ33964135
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposureQ34156588
The pathogenesis of coeliac diseaseQ34273611
Glutamate receptor ion channelsQ34421735
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac diseaseQ34491101
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.Q34518641
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell linesQ34566764
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell linesQ35047377
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.Q35598393
The tight junction: a multifunctional complexQ35777543
Reprogramming of CTLs into natural killer-like cells in celiac diseaseQ36238119
Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the central nervous system: potential therapy for inflammatory demyelinating disease?Q36268431
Regulation of the T cell responseQ36643790
Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut.Q36765830
Understanding the molecular basis of celiac disease: what genetic studies revealQ36793674
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxisQ38407325
Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac diseaseQ40246836
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 functionQ40554316
Toxicity of Wheat Flour Proteins and Protein-Derived Peptides for In Vitro Developing Intestine from Rat FetusQ41137271
CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytesQ41809743
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines.Q44132607
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.Q46023372
Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokinesQ46722581
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammationQ46941338
gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expressionQ48514321
Human zonulin, a potential modulator of intestinal tight junctions.Q52162731
Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins.Q52565792
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.Q53912466
Neutrophil Recruitment and Barrier Impairment in Celiac Disease: A Genomic StudyQ56968899
Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac diseaseQ69122613
Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brainQ73315921
Intraepithelial lymphocytes in celiac diseaseQ73555734
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptorQ73769783
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cellsQ74321391
Evidence for NK cell subsets based on chemokine receptor expressionQ79370190
MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNAQ82616645
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)194-204.e3
P577publication date2008-07-01
P1433published inGastroenterologyQ4039279
P1476titleGliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3
P478volume135

Reverse relations

cites work (P2860)
Q57534899A Grounded Guide to Gluten: How Modern Genotypes and Processing Impact Wheat Sensitivity
Q38199096A metabolomic perspective on coeliac disease.
Q33990012Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil
Q38126789Advances in the treatment of coeliac disease: an immunopathogenic perspective
Q89687580All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases
Q35895022Analysis of Body Composition and Food Habits of Spanish Celiac Women.
Q37142030Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations.
Q26859130Animal models to study gluten sensitivity
Q34500800Anti-gluten immune response following Toxoplasma gondii infection in mice
Q34676184Antibodies to the wheat storage globulin Glo-3A in children before and at diagnosis of celiac disease
Q57937529Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study
Q57839976Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease?
Q36494385Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea
Q38608380Autoimmune diseases and celiac disease which came first: genotype or gluten?
Q28244133Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling
Q99237719Bacteria Remediate the Effects of Food Additives on Intestinal Function in an in vitro Model of the Gastrointestinal Tract
Q34068869Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-
Q59813523Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies
Q38919389Celiac Disease: Role of the Epithelial Barrier
Q33696823Celiac disease
Q34367160Celiac disease and autoimmune-associated conditions
Q28290840Celiac disease and autoimmunity: review and controversies
Q38161565Celiac disease and endocrine autoimmune disorders in children: an update
Q37729522Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity?
Q50876572Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells.
Q42730481Celiac disease: Alternatives to a gluten free diet.
Q92086063Celiac disease: a comprehensive current review
Q34809320Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms
Q37841101Celiac disease: a model disease for gene-environment interaction
Q38669146Celiac disease: from etiological factors to evolving diagnostic approaches
Q34903220Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.
Q22305490Celiac disease: prevalence, diagnosis, pathogenesis and treatment
Q40416734Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients
Q28242747Coeliac disease
Q28266589Coeliac disease and autoimmune disease-genetic overlap and screening
Q64054641Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers
Q89835386Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA
Q27014843Current and emerging therapy for celiac disease
Q47207029Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation
Q34022801Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.
Q60954896Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis
Q26823584Dietary gluten and the development of type 1 diabetes
Q38973710Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion
Q84479921Dietary strategies of immunomodulation in infants at risk for celiac disease
Q35021259Digested wheat gluten inhibits binding between leptin and its receptor
Q36186148Discerning the role of Bacteroides fragilis in celiac disease pathogenesis
Q37067281Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.
Q34668296Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity
Q37704533Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet
Q38080687Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis
Q28069901Elderly Onset Celiac Disease: A Narrative Review
Q38286185Emerging drugs for celiac disease
Q36676716Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet.
Q46057460Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease.
Q35442538Epithelial transport of immunogenic and toxic gliadin peptides in vitro
Q64967668Evolving Therapy for Celiac Disease.
Q34793653Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin
Q27317169Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1
Q55471111Gliadin Peptide Facilitates FITC Dextran Transport across the Non Everted Gut Sac of Rat Small Intestine.
Q41951345Gliadin fragments promote migration of dendritic cells
Q26775020Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications
Q43049444Gliadins induce TNFalpha production through cAMP-dependent protein kinase A activation in intestinal cells (Caco-2).
Q48117063Gluten-free diet exclusively during pregnancy alleviates the signs of diabetes and celiac disease in NOD mouse offspring
Q51287171Gluten-free diet increases beta-cell volume and improves glucose tolerance in an animal model of type 2 diabetes.
Q38685400Gut Microbiota and Celiac Disease
Q55342876Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients.
Q35026379Hepatic manifestations of celiac disease
Q51657347High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
Q34679342Human Intestinal Barrier Function in Health and Disease
Q64064503Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease
Q82527134Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease
Q34612493Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Q34764938IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia
Q47251751Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction
Q38783192Immunopathogenesis and therapeutic approaches in pediatric celiac disease
Q40234173Impact of gluten consumption in patients with functional dyspepsia: a case-control study
Q36344842Important lessons derived from animal models of celiac disease.
Q41881259Increased plasma zonulin in patients with sepsis
Q89553143Increasing incidence of inflammatory bowel disease in children and adolescents: the significance of the environmental factors
Q47999881Inhibition of epithelial growth factor receptor signalling does not preserve epithelial barrier function after in vitro gliadin insult
Q90460272Intestinal Barrier Function in Gluten-Related Disorders
Q38810502Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel
Q28250081Intestinal barrier function: molecular regulation and disease pathogenesis
Q47104884Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease.
Q28273316Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications
Q37723494Intestinal stem cells and celiac disease
Q37638684Investigational therapies for celiac disease
Q64261314Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage
Q37980043Is the origin of type 1 diabetes in the gut?
Q35655989Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.
Q28253767Leaky gut and autoimmune diseases
Q41994459Liver involvement in celiac disease
Q38508755Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease
Q34656866Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.
Q35785774Matriptase protects against experimental colitis and promotes intestinal barrier recovery
Q55424073Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation.
Q34798574Modeling of celiac disease immune response and the therapeutic effect of potential drugs
Q41173044New and developing therapies for celiac disease
Q22252345Non-celiac gluten sensitivity: A work-in-progress entity in the spectrum of wheat-related disorders
Q26772345Nutritional Keys for Intestinal Barrier Modulation
Q28742767Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice
Q34712071Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation.
Q36943034Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall
Q39111493Physiopathology and Management of Gluten-Induced Celiac Disease
Q59809154Possible Prevention of Diabetes with a Gluten-Free Diet
Q38837940Potential role of CXCR3 in proliferation and invasion of prostate cancer cells
Q34623902Prevention measures and exploratory pharmacological treatments of celiac disease.
Q36218896Proinflammatory cytokine interferon-γ and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease
Q34202899Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants
Q47856590Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin-Trypsin-Resistant Gliadin-Induced Tight Junction Injuries
Q64103840RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis
Q84247295Recent advances in celiac disease
Q34287155Regulation of intestinal epithelial permeability by tight junctions.
Q50116104Relationship between G proteins coupled receptors and tight junctions
Q34283907Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat
Q34253519Review article: coeliac disease, new approaches to therapy.
Q35106620Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease
Q30421083Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.
Q47724556Screening for celiac disease, by endomysial antibodies, in patients with unexplained hypertransaminasaemia
Q33823449Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder
Q44117944Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.
Q47842891Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.
Q38510131Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability
Q38021639Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes
Q59794324The Effect of Dietary Mushroom on Intestinal Microbiota Composition and Host Immunological Function
Q58604414The Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial
Q38955820The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Q90567912The Gut Microbiota in Celiac Disease and probiotics
Q64905599The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study.
Q35668237The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.
Q90684083The Janus Face of Cereals: Wheat-Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High-Fat/High-Sucrose Diet
Q37717761The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity
Q26783642The Role of Gluten in Celiac Disease and Type 1 Diabetes
Q90345025The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
Q26778458The Spectrum of Differences between Childhood and Adulthood Celiac Disease
Q34332412The dietary intake of wheat and other cereal grains and their role in inflammation
Q28261350The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis
Q26771888The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate
Q27007776The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease
Q34665037The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders.
Q51822901The significance of coeliac disease antibodies in patients with ankylosing spondylitis: a case-controlled study.
Q26825413Therapeutic approaches for celiac disease
Q28249095Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms
Q37638199Tissue-mediated control of immunopathology in coeliac disease
Q45940827Toxic peptides in Frazer's fraction interact with the actin cytoskeleton and affect the targeting and function of intestinal proteins.
Q89896536Transcriptional and Ultrastructural Analyses Suggest Novel Insights into Epithelial Barrier Impairment in Celiac Disease
Q38269678Transglutaminase as a therapeutic target for celiac disease
Q52358106Translational Chemistry Meets Gluten-Related Disorders.
Q37125463What role does wheat play in the symptoms of irritable bowel syndrome?
Q34315374Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4
Q90565703Wheat gluten intake increases the severity of experimental colitis and bacterial translocation by weakening of the proteins of the junctional complex
Q90257092Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity
Q38830164Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model
Q39103865Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
Q34283930Zonulin, regulation of tight junctions, and autoimmune diseases

Q279074gliadindescribed by sourceP1343

Search more.